1. U.S. Department of Health and Human Services. Guidelines for the Clinical Evaluation of Anti-Inflammatory and Anti-rheumatic Drugs (Adults and Children). Public Health Service, Food and Drug Administration, April 1988.
2. World Health Organization. Guidelines for the Clinical Investigation of Drugs Used in Rheumatic Diseases, European Drug Guidelines Series 5. World Health Organization, Regional Office for Europe, Copenhagen, European League Against Rheumatism March 1985.
3. Fibromyalgia;N. Bellamy,1993
4. Bellamy N, Buchanan WW, Esdaile JM et al. Ankylosing spondylitis antirheumatic drug trials. I. Effects of standardization procedures on observer dependent outcome measures. J Rheumatol. 1991;18:1701–8.
5. Bellamy N, Buchanan WW, Esdaile JM et al. Ankylosing spondylitis. II. Tables for calculating sample size for clinical trials of antirheumatic drugs. J Rheumatol. 1991;18:1709–15.